HOYA - YOUR PARTNER IN CELL THERAPY

Helping our clients turn science into medicines with sound business profiles, while making a meaningful impact on patients’ lives.

Driving the promise of hPSC derived medicines

Bring your cell therapy aspirations to ‘the bedside’ and to commercialisation for patients in need. Harness our network and know-how in hPSC-based cell therapy manufacturing and venture creation.

hPSC-ATMP manufacture - Where are we now?

Read the first in our series of white papers as a follow-up to the 'Tillväxtverket pilot study for hPSC derived cell therapies Innovation catalyst'.

Unlock the World of HOYA Member’s Portal

Are you ready to delve into the exclusive world of HOYA Membership? Elevate your knowledge and expand your network in the field of induced pluripotent stem cells (iPSC). Our member portal is a gateway to invaluable resources, insights, and connections.

To explore the benefits of HOYA Membership and start your journey towards excellence, simply click below and find out more.

Press here to read more

〰️

Press here to read more 〰️

Clients and collaborators

Projects completed

 

Ready to morph your science into business? Let us help you succeed.

We are a team of experts specializing in supporting cell therapy ventures seeking to successfully commercialize research competencies. With our help, we guarantee a shorter time to market, a simplified transition from academia to industry and much more to that.

 

TEAM

  • ANNA FALK, Prof.

    hiPSC researcher and Principal Investigator

    Based in Lund & Stockholm, SE.

  • Oranssi project manager Jaya Dixo

    HEATHER MAIN, PhD

    hPSC-ATMP developer, Communication and Project Management

    Based in Melbourne, AU.

  • Oranssi general contractor Reese Platt

    AJDIN JAKUPOVIC, Dual M.Sc.

    Project Management, Business Development, Market Analysis

    Based in Stockholm, SE.

What our clients say

  • "The team consisting of Anna, Ajdin and Heather made sure to deliver above and beyond our requirements and expectations"

    Tillväxtverket

  • "With the help from HOYA we are now confident in approaching investors in search of funding"

    Swedish biotech company

  • "We recommend HOYA to life science ventures seeking to accelerate their transition from academia - they made the transition much smoother"

    David

    Professor and co-founder of small-sized life science venture

  • "GMP translation of a cell-based therapy is overwhelming. As an academic, you cannot begin to comprehend what it takes till you set off on that dark forest path."

    Heather Main, Karolinska Institutet

Contact us